GPT and metabolic dysfunction-associated steatohepatitis: However, studies have shown that 25% of NAFLD patients and 19% of NASH patients exhibit normal ALT levels in clinical manifestations, underscoring the need for further validation of ALT’s diagnostic utility in NAFLD/NASH (19).